21 insiders reported 120 Form 4 transactions for Heartflow, Inc. (HTFL) over the past 18 months (most recent 2026-06-26). Recent activity: Farquhar John C.M. (Chief Executive Officer) Sell 38,900 shares, Rogers Campbell (Chief Medical Officer) Buy 10,000 shares, Farquhar John C.M. (Chief Executive Officer) Sell 22,562 shares, Rogers Campbell (Chief Medical Officer) Buy 9,219 shares, Rogers Campbell (Chief Medical Officer) Sell 9,219 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-26 | Farquhar John C.M. | Chief Executive Officer | Sell | 38,900 | $1.4M |
| 2026-06-17 | Rogers Campbell | Chief Medical Officer | Buy | 10,000 | $22,200 |
| 2026-06-12 | Farquhar John C.M. | Chief Executive Officer | Sell | 22,562 | $643,017 |
| 2026-05-20 | Rogers Campbell | Chief Medical Officer | Buy | 9,219 | $175,161 |
| 2026-05-20 | Rogers Campbell | Chief Medical Officer | Sell | 9,219 | $261,266 |
| 2026-05-13 | Farquhar John C.M. | Chief Executive Officer | Sell | 22,562 | $657,005 |
| 2026-05-08 | Farquhar John C.M. | Chief Executive Officer | Sell | 1,904 | $57,082 |
| 2026-05-08 | Jones Marie L. | Chief Accounting Officer | Sell | 485 | $14,691 |
| 2026-05-08 | Rogers Campbell | Chief Medical Officer | Sell | 1,634 | $49,494 |
| 2026-05-08 | Verghese Vikram | Chief Financial Officer | Sell | 1,536 | $46,525 |
| 2026-05-08 | Jones Marie L. | Chief Accounting Officer | Sell | 82 | $2,458 |
| 2026-05-08 | Rogers Campbell | Chief Medical Officer | Sell | 637 | $19,097 |
| 2026-05-08 | Farquhar John C.M. | Chief Executive Officer | Sell | 5,300 | $160,537 |
| 2026-05-08 | Verghese Vikram | Chief Financial Officer | Sell | 473 | $14,181 |
| 2026-04-30 | BCLS Fund III Investments, LP | Insider | Sell | 254,110 | $7.8M |
| 2026-04-30 | Bain Capital Life Sciences Investors, LLC | Insider | Sell | 254,110 | $7.8M |
| 2026-04-30 | Bain Capital Life Sciences Fund III, L.P. | Insider | Sell | 254,110 | $7.8M |
| 2026-04-30 | BCLS Fund III Investments GP, LLC | Insider | Sell | 254,110 | $7.8M |
| 2026-04-30 | Bain Capital Life Sciences III General Partner, LLC | Insider | Sell | 254,110 | $7.8M |
| 2026-04-30 | Bain Capital Life Sciences III General Partner, LLC | Insider | Sell | 797,133 | $23.4M |
| 2026-04-30 | BCLS Fund III Investments, LP | Insider | Sell | 797,133 | $23.4M |
| 2026-04-30 | Bain Capital Life Sciences Fund III, L.P. | Insider | Sell | 797,133 | $23.4M |
| 2026-04-30 | BCLS Fund III Investments GP, LLC | Insider | Sell | 797,133 | $23.4M |
| 2026-04-30 | Bain Capital Life Sciences Investors, LLC | Insider | Sell | 797,133 | $23.4M |
| 2026-04-30 | Bain Capital Life Sciences III General Partner, LLC | Insider | Sell | 892,533 | $26.0M |
Source: SEC Form 4 filings · as of 2026-06-26